PLAKOUS THERAPEUTICS
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
PLAKOUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Winston Salem, North Carolina, United States
Country:
United States
Website Url:
http://www.plakoustherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
336-782-3106
Email Addresses:
[email protected]
Total Funding:
3.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Divi Page Links To
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Current Employees Featured
Founder
Investors List
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
Official Site Inspections
http://www.plakoustherapeutics.com Semrush global rank: 5.87 M Semrush visits lastest month: 1.41 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plakous Therapeutics" on Search Engine
Leadership - Plakous Therapeutics
Robert Boyce. Chief Executive Officer. Rob Boyce is the CEO of Plakous Therapeutics, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. …See details»
Plakous Therapeutics - Crunchbase Company Profile
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing …See details»
Behind Our Science - Plakous Therapeutics
Plakous Therapeutics. Our expertise in biotechnology, biopharma and regenerative medicine is changing the game in inflammatory treatment, offering a new approach to …See details»
Plakous Therapeutics | LinkedIn
About us. Website. https://plakoustherapeutics.com/ Industry. Biotechnology Research. Company size. 2-10 employees. Headquarters. Winston-Salem, NC. Type. Privately …See details»
Plakous Therapeutics - Funding, Financials, Valuation
Plakous Therapeutics has raised a total of. $3.7M. in funding over 7 rounds. Their latest funding was raised on Dec 20, 2022 from a Grant round. Plakous Therapeutics is …See details»
Plakous Therapeutics Announces New Funding to …
Jul 05, 2022, 11:55 ET. Share this article. WINSTON-SALEM, N.C., July 5, 2022 /PRNewswire/ -- Plakous Therapeutics, Inc. today announced it is has received more …See details»
Plakous Therapeutics Awarded Phase II SBIR Grant …
Aug 10, 2021 Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived regenerative therapies to improve patient …See details»
Plakous Therapeutics Announces New Funding to Support
Jul 5, 2022 Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived regenerative therapies to improve patient outcomes …See details»
Triad Inno - Plakous Therapeutics looks to raise $10M for …
July 12, 2022, 02:19pm EDT. After winning a total of $60,000 in the NC BIONEER Venture Challenge, Plakous Therapeutics received a $250,000 loan from the N.C. Biotechnology Center as it looks to...See details»
Plakous Therapeutics Awarded Phase II SBIR Grant from NIH to …
WINSTON-SALEM, N.C., Aug. 10, 2021 /PRNewswire/ -- Plakous Therapeutics, Inc. received a notice of award for Phase II of its Small Business Innovation Research …See details»
Plakous Therapeutics lands $310,000 in funding from NC Biotech …
By Jason Parker — July 5, 2022. WINSTON-SALEM – Plakous Therapeutics today disclosed that the total funding the the Winston-Salem-headquartered biotherapeutic company has received through North...See details»
Plakous Therapeutics Wins NC BIONEER Venture Challenge
Jun 24, 2022 Winston-Salem-based Plakous Therapeutics has won the 2022 NC BIONEER Venture Challenge. The announcement was made at Triad BioNight, a …See details»
News - Plakous Therapeutics
Jun 18. FDA Designations. Plakous Therapeutics, Inc. has been granted orphan drug and rare pediatric disease designations for its human placental extract, Protego-PDTM for …See details»
Plakous Therapeutics, Inc. - BIO International Convention | BIO
Jun 6, 2023 Plakous is a biotherapeutic company developing a patented platform that, in preclinical studies, demonstrated efficacy in preventing the rare pediatric disease, …See details»
Plakous Therapeutics - Contacts, Employees, Board Members, …
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.See details»
Plakous Therapeutics Receives Rare Pediatric Disease and …
Jun 19, 2020 Plakous Therapeutics is a patient-focused biotherapeutic company that is dedicated to researching and developing regenerative therapies to improve patient …See details»
Plakous Therapeutics LLC | VentureRadar
Location: USA. Founded in 2016. Private Company. "Plakous Therapeutics is developing biotherapeutics from post-delivery placenta to promote regenerative healing for diseases …See details»
Plakous Therapeutics | CipherBio
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing. Stage: Public. Total Funds Raised: $0.00. Funding Products …See details»
Value of Human Placental Extract (HPE) - Plakous Therapeutics
Value of Human Placental Extract (HPE) - Plakous Therapeutics. Human Placental Extract (HPE) Preclinical Milestones & Timeline. Necrotizing Enterocolitis. Pre-Clinical Efficacy. …See details»
Grant - Plakous Therapeutics - 2022-12-20 - Crunchbase
Dec 20, 2022 Organization Name. Plakous Therapeutics. Announced Date Dec 20, 2022. Funding Type Grant. Money Raised. $10K. Lead Investors. Altis Biosystems Altis …See details»